Zoetis Inc. Repayments of Long-Term Debt
Zoetis Inc. (ZTS) reported Repayments of Long-Term Debt of $1.35 billion for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-02-12
- Zoetis Inc. repayments of long-term debt for the quarter ending 2025-12-31 was $0.00.
- Zoetis Inc. repayments of long-term debt for the quarter ending 2024-12-31 was $0.00.
- Zoetis Inc. repayments of long-term debt for the quarter ending 2024-09-30 was $0.00.
- Zoetis Inc. repayments of long-term debt for the quarter ending 2024-06-30 was $0.00.
- Zoetis Inc. repayments of long-term debt for fiscal 2025 was $1.35B.
- Zoetis Inc. repayments of long-term debt for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Zoetis Inc. repayments of long-term debt for fiscal 2023 was $1.35B.
- Zoetis Inc. repayments of long-term debt for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $1.35B 10-K · filed 2026-02-12 | ||
| 2025-09-30 | $1.35B 10-Q · filed 2025-11-04 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $0.00 derived: sum of 2 quarters · filed 2026-02-12 | $0.00 derived: sum of 3 quarters · filed 2026-02-12 | $0.00 10-K · filed 2026-02-12 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $0.00 derived: sum of 2 quarters · filed 2025-11-04 | $0.00 10-Q · filed 2025-11-04 | $0.00 derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $0.00 10-Q · filed 2024-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-02-12 | $0.00 derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-02 | $0.00 derived: sum of 2 quarters · filed 2026-02-12 | $0.00 derived: sum of 3 quarters · filed 2026-02-12 | $0.00 derived: sum of 4 quarters · filed 2026-02-12 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $0.00 derived: sum of 2 quarters · filed 2026-02-12 | $0.00 derived: sum of 3 quarters · filed 2026-02-12 | $1.35B 10-K · filed 2026-02-12 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $0.00 derived: sum of 2 quarters · filed 2024-11-04 | $1.35B 10-Q · filed 2024-11-04 | $1.35B derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $1.35B 10-Q · filed 2024-08-06 | $1.35B derived: sum of 3 quarters · filed 2025-02-13 | $1.35B derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | $1.35B 10-Q · filed 2024-05-02 | $1.35B derived: sum of 2 quarters · filed 2025-02-13 | $1.35B derived: sum of 3 quarters · filed 2025-02-13 | $1.35B derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $0.00 derived: sum of 2 quarters · filed 2025-02-13 | $0.00 derived: sum of 3 quarters · filed 2025-02-13 | $0.00 10-K · filed 2025-02-13 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | $0.00 10-Q · filed 2023-11-02 | $0.00 derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | $0.00 derived: sum of 3 quarters · filed 2024-02-13 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 | $0.00 derived: sum of 2 quarters · filed 2024-02-13 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $600.00M 10-K · filed 2024-02-13 | ||
| 2021-09-30 | $600.00M 10-Q · filed 2022-11-03 | |||
| 2020-12-31 | $500.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $500.00M 10-K · filed 2023-02-14 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-04 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-15 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-16 | |||
| 2017-12-31 | $750.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $750.00M derived: sum of 2 quarters · filed 2020-02-13 | $750.00M derived: sum of 3 quarters · filed 2020-02-13 | $750.00M 10-K · filed 2020-02-13 |
| 2017-10-01 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $0.00 derived: sum of 2 quarters · filed 2017-11-02 | $0.00 10-Q · filed 2017-11-02 | $0.00 derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-07-02 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $0.00 10-Q · filed 2017-08-08 | $0.00 derived: sum of 3 quarters · filed 2019-02-14 | $0.00 derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-04-02 | $0.00 10-Q · filed 2017-05-04 | $0.00 derived: sum of 2 quarters · filed 2019-02-14 | $0.00 derived: sum of 3 quarters · filed 2019-02-14 | $0.00 derived: sum of 4 quarters · filed 2019-02-14 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $0.00 derived: sum of 2 quarters · filed 2019-02-14 | $0.00 derived: sum of 3 quarters · filed 2019-02-14 | $400.00M 10-K · filed 2019-02-14 |
| 2016-10-02 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $0.00 derived: sum of 2 quarters · filed 2017-11-02 | $400.00M 10-Q · filed 2017-11-02 | $400.00M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-07-03 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $400.00M 10-Q · filed 2017-08-08 | $400.00M derived: sum of 3 quarters · filed 2018-02-15 | $400.00M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-04-03 | $400.00M 10-Q · filed 2017-05-04 | $400.00M derived: sum of 2 quarters · filed 2018-02-15 | $400.00M derived: sum of 3 quarters · filed 2018-02-15 | $400.00M derived: sum of 4 quarters · filed 2018-02-15 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $0.00 derived: sum of 2 quarters · filed 2018-02-15 | $0.00 derived: sum of 3 quarters · filed 2018-02-15 | $0.00 10-K · filed 2018-02-15 |
| 2015-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $0.00 derived: sum of 2 quarters · filed 2016-11-03 | $0.00 10-Q · filed 2016-11-03 | |
| 2015-06-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $0.00 10-Q · filed 2016-08-05 | ||
| 2015-03-29 | $0.00 10-Q · filed 2016-05-06 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-02-16 | |||
| 2013-12-31 | $0.00 10-K · filed 2014-03-26 | |||
| 2012-12-31 | $0.00 10-K · filed 2014-03-26 | |||
| 2011-12-31 | $143.00M 10-K · filed 2014-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |